LivaNova PLC (id:7506 LIVN)
46.93 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 12/24/2024 11:16:07 AM)
Exchange open, closes in 4 hours 43 minutes
About LivaNova PLC
Market Capitalization 2.59B
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
| Headquarters (address) |
20 Eastbourne Terrace London W2 6LG United Kingdom |
| Phone | 44 20 3325 0660 |
| Website | https://www.livanova.com |
| Employees | 3K |
| Sector | Healthcare |
| Industry | Medical Devices |
| Ticker | LIVN |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 43.15 - 64.48 |
| Market Capitalization | 2.59B |
| P/E trailing | 110.80 |
| P/E forward | 12.88 |
| Price/Sale | 2.08 |
| Price/Book | 1.97 |
| Beta | 1.01 |
| EPS | 3.00 |
| EPS United Kingdom (ID:3, base:630) | 3.00 |